Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Analysis of cancer mortality trends reveals disparities for Hispanic populations
While cancer mortality rates in the U.S. have decreased, cancer remains the leading cause of…
New AI platform targets safe use of medicines after patients leave hospital
A major new $2.9 million digital health project led by Flinders University will target the…
What are the endometrial cancer risks and trends among different African descent populations?
Compared with white women, Black women have elevated risks of being diagnosed with advanced uterine…
Polygenic risk scores could improve colorectal cancer screening
- First randomised controlled trial of genetic counselling for familial and inherited colorectal cancer shows significant improvements in patient empowerment
- Precancerous growths in colon linked to microbiome changes
- ASCO 2023: Study may provide clues to treating colorectal cancer more effectively in younger patients
Novel technology makes biopsies less invasive and more informative
A team of researchers from the National University of Singapore (NUS) has developed a novel technology that could sensitively and…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.